— The objective of the present study was to assess the possible tumour promoting activity of the food mutagen 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP), by studying its influence on the expression of three genes considered to be of relevance in the tumour promotion step. The genes were two proto-oncogenes, c-fos and c-myc, and the tumour suppressor gene, p53. We observed that the expression of the c-fos and c-myc genes was induced when human bladder epithelial cells were treated with a standard solution of N-OH-PhIP and dithiothreitol (DTT), previously shown to be genotoxic. However, when cells were treated with DTT alone, the expression of c-fos and c-myc was also transiently induced. We therefore conclude that DTT, and not N-OH-PhIP, induced oncogene expression. Induction of both c-fos and c-myc expression by a reducing agent, DTT, which is frequently used in in vitro toxicology studies, is a novel observation that suggests the need for a cautious interpretation of such studies.
ArmitageP., and DollR. (1954). The age distribution of cancer and multi-stage theory of carcinogenesis.British Journal of Cancer8, 1–12.
2.
SinnE., MullerW., PattengaleP., TeplerI., WallaceR., and LederP. (1987). Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo.Cell49, 465–475.
3.
FearonE.R., and VogelsteinB. (1990). A genetic model for colorectal tumorigenesis.Cell61, 759–767.
4.
MoolgavkarS.H., and KnudsonA.G. (1981). Mutation and cancer: a model for human carcinogenesis.Journal of the National Cancer Institute66, 1037–1052.
5.
SlagaT.J. (1989). Cellular and molecular mechanisms involved in multistage skin carcinogenesis. In Skin Tumors: Experimental and Clinical Aspects (ed. ContiC.J.), pp. 1–18. New York: Raven Press.
6.
ÖvervikE., & GustafssonJ-Å. (1990). Cooked-food mutagens: current knowledge of formation and biological significance.Mutagenesis5, 437–446.
7.
JägerstadtM., SkogK., GrivasS., and OlssonK. (1991). Formation of heterocyclic amines using model systems.Mutation Research259, 219–233.
8.
FeltonJ.S., and KnizeM.G. (1991). Occurrence, identification, and bacterial mutagenicity of heterocyclic amines in cooked food.Mutation Research259, 205–217.
9.
FeltonJ.S., KnizeM.G., ShenN.H., LewisP.R., AndersenB.D., HappeJ., and HatchF.T. (1986). The isolation and identification of a new mutagen from fried ground beef: 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP).Carcinogenesis7, 1081–1086.
10.
FrandsenH., RasmussenE.S., NielsenP.A., FarmerP., DragstedL., and LarsenJ.C. (1991). Metabolic formation, synthesis and genotoxicity of the N-hydroxy derivative of the food mutagen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP).Mutagenesis6, 93–98.
11.
EsumiH. (1989). Induction of lymphoma in CDF1 mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine.Japanese Journal of Cancer Research80, 1176–1178.
12.
OchiaiML, KumikoO., WakabayashiK., SugimuraT., NagaseS., EsumiH., and NagaoM. (1991). Induction of intestinal adenocarcinomas by 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine in Nagase analbuminemic rats.Japanese Journal of Cancer Research82, 363–366.
13.
TakahashiS., OgawaK., OshimaH., EsumiH., ItoN., and SugimuraT. (1991). Induction of aberrant crypt foci in the large intestine of F344 rats by oral administration of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine.Japanese Journal of Cancer Research82, 135–137.
14.
ThomsonL.H., TuckerJ.D., StewartS.A., ChristensonM.L., SalazerE.P., CarranoA.V., and FeltonJ.S. (1987). Genotoxicity of compounds from cooked beef in repair-deficient CHO cells versus Salmonella mutagenicity.Mutagenesis2, 483–487.
15.
HolmeJ.A., WallinH., BrunborgG., SønderlandE.J., HongsloJ.K., and AlexanderJ. (1989). Genotoxicity of the food mutagen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP); formation of 2-hydroxyamino-PhIP, a direct acting genotoxic metabolite.Carcinogenesis10, 1389–1396.
16.
KinsellaA.R., and RadmanM. (1978). Tumor promoter induces sister-chromatid exchanges: relevance to mechanisms of carcinogenesis.Proceedings of the National Academy of Sciences of the United States of America75, 6149–6153.
17.
VarshavskyA. (1981). Phorbol ester dramatically increases incidence of methotrexate-resistant mouse cells: possible mechanisms and relevance to tumor promotion.Cell25, 561–572.
18.
FärberB., and KinzelV. (1990). Distribution of phorbol ester TPA-induced structural chromosomal aberrations in HeLa cells.Carcinogenesis11, 2067–2070.
19.
WeinsteinI.B. (1991). Nonmutagenic mechanisms in carcinogenesis: role of protein kinase C in signal transduction and growth control.Environmental Health Perspectives93, 175–179.
20.
CohenS.M., EllweinL., and JohanssonS.L. (1987). Bladder tumor promotion. In Banbury Report No. 25: Non-genotoxic Mechanisms in Carcinogenesis (ed. ButterworthB.E., SlagaT.J.), pp. 55–67. New York: Cold Spring Harbor Laboratory.
21.
RahmsdorfH.J., and HerrlichP. (1990). Regulation of gene expression by tumor promoters.Pharmacology & Therapeutics48, 157–188.
22.
DrinkwaterN.R. (1990). Experimental models and biological mechanisms for tumor promotion.Cancer Cells2, 8–15.
23.
SkouvJ., JensenP., ForchhammerJ., LarsenJ.K., and LundL.R. (1994). Tumor-promoting phorbol ester transiently down-modulates the p53 level and blocks the cell cycle.Cell Growth & Differentiation5, 329–340.
24.
ChristensenB., KielerJ., VilienM., DonP., WangC.Y., and WolfH. (1984). A classification of human urothelial cells propagated in vitro.Anticancer Research4, 319–337.
25.
FeinbergA.P., and VogelsteinB. (1993). A technique for radiolabelling DNA restriction endo-nuclease fragments to high specific activity.Analytical Biochemistry132, 6–13.
26.
CurranT., PetersC., Van BeverenC., TeichN.M., and VermaI.M. (1982). FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA.Journal of Virology44, 674–682.
27.
FortP., MartyL., PiechaczykM., el-SabroutyS., DaniC., JeanteurP., and BlanchardJ.M. (1985). Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family.Nucleic Acids Research13, 1431–1442.
28.
ChirwinJ.M., PrzybylaA.E., MacDonaldR.J., and RutterW.J. (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.Biochemistry18, 5294–5299.
29.
SkouvJ., ChristensenB., SkibshøjI., and AutrupH. (1986). The skin tumor promoter 12-O-tetra-decanoylphorbol-13-acetate induces transcription of the c-fos proto-oncogene in human bladder epithelial cells.Carcinogenesis7, 331–333.
30.
ThomasP. (1980). Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.Proceedings of the National Academy of Sciences of the United States of America77, 5201–5205.
31.
McMasterG.K., and CarmicalG.C. (1977). Analysis of single and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.Proceedings of the National Academy of Sciences of the United States of America74, 4835–4841.
32.
SkouvJ., OttesenS., MarkG., and AutrupH. (1989). Malignant transformation of human' bladder epithelial cells by DNA transfection with the v-raf oncogene.Molecular Carcinogenesis2, 59–62.
33.
SlamonD.J., deKernionJ.B., VermaI.M., and ClineM.J. (1984). Expression of cellular oncogenes in human malignancies.Science224, 256–262.
34.
RollinsB.J., and StilesC.D. (1989). Serum-inducible genes.Advances in Cancer Research53, 1–32.
35.
MeichleA., PhilippA., and EilersM. (1992). The functions of myc proteins.Biochimica et Biophysica Acta114, 129–146.
36.
XanthoudakisS., MiaoG., WangF., PanY.C., and CurranT. (1992). Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme.EMBO Journal11, 3323–3335.
37.
CurranT., and FranzaB.R. (1988). Fos and jun: the AP1 connection.Cell55, 395–397.
38.
AbateC., PatelL., RauscherF.J., and CurranT. (1990). Redox regulation of fos and jun DNA-binding activity in vitro.Science249 (4973), 1157–1161.
39.
AngelI.P., ImagawaM., ChiuR., SteinB., ImbraR.J., RahmsdorfJ.J., JonatC., HerlichP., and KaraM. (1987). Phorbol ester-inducible genes contain a common cis element recognised by a TPA-modulated trans-acting factor.Cell49, 729–739
40.
LeeW., MitchellP., and TjianR. (1987). Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements.Cell49, 741–752.
41.
MarcuK.B., BossoneS.A., and PatelA.J. (1992). Myc function and regulation.Annual Review of Biochemistry61, 809–860.
42.
CastagnaM. (1987). Phorbol esters as signal transducers and tumor promoters.Biology of the Cell59, 3–13.
43.
YuspaS.H., and PoirierM.C. (1988). Chemical carcinogenesis: from animal models to molecular models in one decade.Advances in Cancer Research50, 25–70.
44.
DrohmsK.A., and MalkinsonA.M. (1991). Phorbol ester in promotion by down-regulation of protein kinase C.Molecular Carcinogenesis4, 1–2.
